SCHEMBL5606530

SCHEMBL5606530

Cc1ccc(Oc2ccc(C#N)cc2)c(O)c1

nearest known ligand 0.63

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
AR P10275 5/20 0.59
ALDH1A1 P00352 1/20 0.47
CYP2A6 P11509 1/20 0.47
TBXA2R P21731 3/20 0.45
CYP11B1 P15538 2/20 0.43
SLC6A4 P31645 1/20 0.42
PARP15 Q460N3 1/20 0.41
PARP10 Q53GL7 1/20 0.41
PARP2 Q9UGN5 1/20 0.41
CYP11B2 P19099 1/20 0.41
KDM4E B2RXH2 1/20 0.41
MEN1 O00255 1/20 0.41
LMNA P02545 1/20 0.41
POLB P06746 1/20 0.41
MAPT P10636 1/20 0.41
PKM P14618 1/20 0.41
MAPK1 P28482 1/20 0.41
RAB9A P51151 1/20 0.41
KMT2A Q03164 1/20 0.41
IL18 Q14116 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16309243 0.84 AR (0.54) ARALDH1A1MEN1LMNAPOLB
SCHEMBL922953 0.83 AR (0.62) ARALDH1A1CYP2A6TBXA2RSLC6A4
SCHEMBL5606511 0.81 AR (0.82) ARALDH1A1CYP2A6TBXA2RSLC6A4
SCHEMBL328391 0.81 AR (0.59) ARALDH1A1CYP2A6TBXA2RSLC6A4
SCHEMBL922684 0.80 AR (0.58) ARALDH1A1CYP2A6TBXA2RCYP11B1
SCHEMBL5607469 0.78 TEAD4 (0.57) ARALDH1A1POLBMAPT
SCHEMBL12386586 0.78 AR (0.49) ARALDH1A1TBXA2RSLC6A4KDM4E
SCHEMBL7006874 0.78 TTR (0.61) ARALDH1A1KDM4E
SCHEMBL29355313 0.78 TTR (0.61) ARALDH1A1KDM4E
SCHEMBL6295004 0.77 AR (0.55) ARALDH1A1CYP2A6TBXA2RCYP11B1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1838300-A2 2-(2 OR 4-SUBSTITUTED ARYLOXY)-PHENOL DERIVATIVES AS ANTIBACTERIAL AGENTS Emergent Product Development Gaithersburg Inc. (US) 2007-10-03 EP disclosed
US-20060211697-A1 2-(2 Or 4-substituted aryloxy)-phenol derivatives as antibacterial agents EMERGENT PRODUCT DEVELOPMENT GAITHERSBURG, INC. 2006-09-21 US disclosed
WO-2006071471-A2 2-(2 OR 4-SUBSTITUTED ARYLOXY)-PHENOL DERIVATIVES AS ANTIBACTERIAL AGENTS EMERGENT PRODUCT DEVELOPMENT GAITHERSBURG INC. (US) 2006-07-06 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060211697-A1 2-(2 Or 4-substituted aryloxy)-phenol derivatives as antibacterial agents TYR, NFE2L2, CYP1A1 AR 1336/4885ALDH1A1 1406/4885CYP2A6 130/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.